ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Aranesp 300 Mikrogramm, Injektionslösung in Fertigspritze - Spritze(n)
55725071 Amgen Switzerland AG
Aranesp 300 Mikrogramm, Injektionslösung in Fertigspritze13.09.2002
  13.09.2002
Darbepoetin Alfa (B03XA02)19.11.2007
WHO-DDD 
06.07.30.Spritze(n)
06.07.30. 
A  
Yes 
IPCI
628.29Yes
    
10 %738.40
7680557250719Biotechnologika
5423142 
Composition
darbepoetinum alfa 300 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml corresp., natrium 2.27 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Darbepoetin Alfa300µg / 0.6ml
BAG: Active AgentDose
Darbepoetin Alfa0.3 mg
 
Inactive agents
Disodium Phosphate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 80
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home